NCT07193875View on ClinicalTrials.gov

Efavirenz (EFV) Intensification

PHASE4CompletedINTERVENTIONAL
Enrollment

7

Participants

Timeline

Start Date

February 9, 2023

Primary Completion Date

December 16, 2024

Study Completion Date

December 16, 2024

Conditions
HIV
Interventions
DRUG

Efavirenz 600mg

Take One pill daily for 6 months in addition to baseline combination antiretroviral therapy regimen

Trial Locations (1)

63110

Washington University in St Louis, St Louis

All Listed Sponsors
lead

Washington University School of Medicine

OTHER

NCT07193875 - Efavirenz (EFV) Intensification | Biotech Hunter | Biotech Hunter